GFAP and Alzheimer disease: [18F]F-DED PET presented an age-dependent increase in binding in an AD animal model (i.e., APP/PS2), and the PET signals in the hippocampus and thalamus positively correlated with MAO-B expression in glial fibrillary acidic protein (GFAP)-positive astrocytes (R > 0.70).